On Monday, Calumet received a positive adjustment to its Relative Strength (RS) Rating, from 63 to 71.
When To Sell Stocks To Lock In Profits And Minimize Losses
This exclusive rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the last 52 weeks compares to all the other stocks in our database.
Over 100 years of market history shows that the top-performing stocks tend to have an 80 or higher RS Rating as they begin their largest runs. See if Calumet can continue to show renewed price strength and hit that benchmark.
While now is not an ideal time to invest, see if the stock is able to form a consolidation and break out.
Calumet reported 0% earnings growth last quarter. Revenue rose -1%.
Calumet holds the No. 19 rank among its peers in the Oil & Gas-Refining/Marketing industry group. UGI, Global Partners and Targa Resources are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
